| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Relay Therapeutics, Inc.'s insiders have reduced their positions by a net 8,660 shares worth roughly $162K.
RLAY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.45M | $28.67M | - | |
| Pres | 409.9K | $8.10M | - | |
| Other | 276.6K | $5.47M | - | |
| CFO | 213.9K | $4.23M | - | |
| Dir | 207.9K | $4.11M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2021 | Third Rock Ventures Iii, L.P.65 | 10% Owner | Sell | 5,622,394 | $40.40 | $227,132,711.61 | -8.9% | |
| Jul 20, 2020 | Patel Sanjiv73 | President And CEO | Buy | 25,000 | $20.00 | $500,000.00 | +6.6% | |
| Jul 20, 2020 | Adams Brian71 | General Counsel | Buy | 10,000 | $20.00 | $200,000.00 | New | |
| Jul 20, 2020 | Murcko Mark | Director | Buy | 25,000 | $20.00 | $500,000.00 | +2.5% | |
| Jul 20, 2020 | Rubin Jami | Director | Buy | 25,000 | $20.00 | $500,000.00 | New | |
| Jul 20, 2020 | Ingram Douglas S | Director | Buy | 25,000 | $20.00 | $500,000.00 | New |